west china medical publishers
Author
  • Title
  • Author
  • Keyword
  • Abstract
Advance search
Advance search

Search

find Author "王永波" 2 results
  • Current status of postoperative specific quality of life and its influencing factors analysis for patients with thyroid cancer

    ObjectiveTo investigate the quality of life (QoL) of patients with differentiated thyroid cancer (DTC) after surgery and analyze its relevant influencing factors. MethodsThe patients with DTC who underwent surgical resection in the First Affiliated Hospital of Zhengzhou University from December 1, 2021 to October 1, 2023 were investigated through the postoperative follow-up platform and follow-up management group. The postoperative QoL of DTC patients were evaluate using the Chinese version of the Thyroid Cancer Specific Quality of Life Questionnaire (THYCA-QoL) specific scale and the Chinese version of the European Organization for Research and Treatment of Cancer (EORTC) developed a quality of life questionnaire consisting of 30 items (QLQ-C30). The higher overall average score of THYCA-QoL scale, the more clinical symptoms of patients, namely the negative QoL. The higher the EORTC QLQ-C30 overall health status score, the better QoL. In addition, multiple linear regression was used to explore the risk factors affecting the postoperative specific QoL score of DTC patients. ResultsA total of 1 076 patients’ questionnaires were collected. The EORTC QLQ-C30 overall health status score of 1 076 patients was 67±22 and the THYCA-QoL overall score was 22±13. The results of multivariate linear regression analysis showed that the early postoperative period (<6 months), male, age, without postoperative lifetime medication and without postoperative iodine-131 radiotherapy had negative effects on the overall score of THYCA-QoL scale (P<0.05), meanwhile the early postoperative period (<6 months) or later (≥12 months), without postoperative lifetime medication and without postoperative iodine-131 radiotherapy had positive effects on the overall health status score of EORTC QLQ-C30 (P<0.05). ConclusionsEORTC QLQ-C30 combined with THYCA-QoL can evaluate not only the common symptoms of cancer, but also the specific symptoms of thyroid cancer after surgery. And understanding the factors affecting the QoL of patients with thyroid cancer after surgery could provide targeted and supportive treatment and nursing for discharged patients to improve the QoL of patients with thyroid cancer after surgery.

    Release date: Export PDF Favorites Scan
  • 地塞米松联合用药方案在原发性甲状腺功能亢进患者术前准备中的临床实践经验

    目的探讨地塞米松联合用药方案在原发性甲状腺功能亢进症(简称 “甲亢” )患者术前准备中应用的效果。方法回顾性收集郑州大学第一附属医院甲状腺外科2021年1月1日至2022年10月1日期间收治的原发性甲亢手术患者。采用地塞米松联合碘剂和β-受体阻滞剂联合应用的7 d术前准备方案(简称 “7 d方案” ):连续口服7 d复方碘溶液(3次/d,0.75 mL/次),在口服复方碘溶液的第5、6、7天时同时加用地塞米松注射液缓慢静脉滴注(1次/d,20 mg/次,上午10∶00开始,每次输入间隔时间24 h),手术前1 d口服β-受体阻滞剂普萘洛尔(剂量因人而异),于术前准备完成后第2天(第8天时)手术。观察入院时及使用地塞米松后的第1、2、3、4、5天时血清促甲状腺激素、游离三碘甲状腺原氨酸(free triiodothyronine,FT3)及游离甲状腺素(free thyroxine,FT4)水平的变化情况以及并发症情况。结果本研究共收集到58例患者,使用地塞米松后第1、2、3、4、5天时的FT3及FT4水平总体一直呈持续下降趋势(F=88.355,P<0.001;F=21.291,P<0.001),并且使用地塞米松后第2天开始FT3均值一直维持在正常水平,FT4均值虽未完全达到正常水平但比较接近正常水平;促甲状腺激素水平总体比较差异无统计学意义(χ2=1.607,P=0.900)。术后未发生甲状腺危象。结论从本研究结果看,“7 d方案”进行术前准备,较传统术前准备方法缩短了术前准备时间,对原发性甲亢的围术期管理安全、有效。

    Release date: Export PDF Favorites Scan
1 pages Previous 1 Next

Format

Content